IBSA Farmaceutici Italia Srl products

Cardiology is the branch of medicine involving the study, diagnosis and treatment of acquired or congenital cardiovascular diseases, which represent the primary cause of mortality and morbidity in Western countries. In addition to treating cardiovascular diseases, heart failure and rhythm disorders, cardiologists also deal with cardiovascular prevention. Over the past two decades, there has been increased interest in omega-3 polyunsaturated fatty acids (PUFA), on account of their lipid-lowering, anti-inflammatory, antiarrhythmic and antithrombotic properties. In addition to being introduced through the diet, omega-3s extracted from fish oils can be prescribed by doctors as medicinal products for the treatment of certain medical conditions.

Aesthetic medicine aims to improve and maintain the aesthetic wellness of the skin through a thorough analysis of the patient’s systemic and local conditions, the formulation of a detailed diagnosis and the creation of therapeutic strategies. In this area, IBSA provides a complete range of products based on the Hydrolift^® action concept. Hydrolift^® Action is a novel approach that aims to counter the physiological decrease in the hyaluronic acid (HA) present in the skin, to restore moisture, elasticity and firmness.

In the Integrative Care area, the company has developed several solutions that help to address better – and in an integrated way – the challenges to which the body is exposed every day. From bone “well-being” and the quality of sleep to the need to make up for any deficiencies occurring in various situations such as pregnancy, stress, anaemia, fatigue and lack of energy. The Integrative Care area also includes a wide range of ophthalmic products suitable for the specific needs of adults and children to relieve redness, dryness, burning, irritation, lacrimation and fatigue – caused by environmental factors and lifestyle. 

Osteoarticular disorders affect approximately 10% of the world population and can be subdivided into inflammatory and degenerative forms. They are usually characterised by a chronic evolution that, when untreated, can result in irreversible damage to the joint structures leading to severe disability and impairment. Rheumatic diseases are painful conditions caused by joint or muscle inflammation, swelling and pain.

The WHO (World Health Organization) considers infertility a disease. According to the various estimates available, infertility affects between 15% and 20% of couples in industrialised countries. Worldwide, some 90 million people have fertility issues, of whom 25 million in Europe, the continent in which the greatest use is made of artificial insemination and where the number of treatment cycles administered rose from 100 thousand in 1995 to 700 thousand in 2014. In recent years, there has been a decrease in the fertility rate all around the world. Even in Africa, where it remains the highest, the number of births per woman slumped from 5.1 in the 2000-2005 period to 4.7 in 2010-2015.